ডেনমার্ক - ডেনিশ - Lægemiddelstyrelsen (Danish Medicines Agency)

ethypharm - adrenalintartrat - injektionsvæske, opløsning - 1 mg/ml

ইউরোপীয় ইউনিয়ন - ডেনিশ - EMA (European Medicines Agency)

teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - medicin for obstruktiv sygdomme, - asthma biresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdbiresp spiromax is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).

ইউরোপীয় ইউনিয়ন - ডেনিশ - EMA (European Medicines Agency)

teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - medicin for obstruktiv sygdomme, - asthma duoresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdduoresp spiromax is indicated in adults, aged 18 years and older for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).

ইউরোপীয় ইউনিয়ন - ডেনিশ - EMA (European Medicines Agency)

chiesi farmaceutici s.p.a. - beclometasone dipropionate, formoterol fumarate dihydrat, glycopyrronium bromid - pulmonal sygdom, kronisk obstruktiv - medicin for obstruktiv sygdomme, - maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and high dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year. copdmaintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or a combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5. asthmamaintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.

ডেনমার্ক - ডেনিশ - Lægemiddelstyrelsen (Danish Medicines Agency)

norgine b.v. - misoprostol - tabletter - 25 mikrogram

ডেনমার্ক - ডেনিশ - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm a/s - formoterolfumarat dihydrat - inhalationsspray, opløsning - 12 mikrogram/dosis

ডেনমার্ক - ডেনিশ - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - budesonid, formoterolfumarat dihydrat - inhalationspulver - 4,5+160 mikrog/dosis

ডেনমার্ক - ডেনিশ - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm a/s - budesonid, formoterolfumarat dihydrat - inhalationspulver - 9+320 mikrog/dosis

ডেনমার্ক - ডেনিশ - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - budesonid, formoterolfumarat dihydrat - inhalationspulver - 9+320 mikrog/dosis

ডেনমার্ক - ডেনিশ - Lægemiddelstyrelsen (Danish Medicines Agency)

amgros i/s - glucosemonohydrat, kaliumchlorid, natriumchlorid, natriumlactat opløsning - infusionsvæske, opløsning - 0,67+1,0+1,56+55 g/l